Scarica l'app Stockscreener
4.10
2.15%
-0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.19
Aprire:
$4.15
Volume 24 ore:
731.58K
Relative Volume:
0.67
Capitalizzazione di mercato:
$279.03M
Reddito:
-
Utile/perdita netta:
$-117.81M
Rapporto P/E:
-2.1809
EPS:
-1.88
Flusso di cassa netto:
$74.30M
1 W Prestazione:
-7.66%
1M Prestazione:
-1.20%
6M Prestazione:
-41.34%
1 anno Prestazione:
+3.27%
Intervallo 1D:
$4.055
$4.19
Intervallo di 1 settimana:
$4.055
$4.595
Portata 52W:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Nome
Omeros Corporation
Settore
Industria
Telefono
206-676-5000
Indirizzo
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Confronta OMER con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.10 | 285.15M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2022-12-08 | Downgrade | UBS | Buy → Neutral |
| 2022-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Downgrade | Maxim Group | Buy → Hold |
| 2021-10-01 | Downgrade | Wedbush | Neutral → Underperform |
| 2021-09-27 | Iniziato | JP Morgan | Neutral |
| 2021-02-01 | Iniziato | UBS | Buy |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-08-21 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-14 | Reiterato | Maxim Group | Buy |
| 2019-05-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Iniziato | Seaport Global Securities | Buy |
| 2018-03-23 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-03-05 | Downgrade | Needham | Buy → Hold |
| 2017-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Reiterato | Maxim Group | Buy |
| 2017-03-17 | Reiterato | Needham | Buy |
| 2016-11-16 | Reiterato | Wedbush | Outperform |
| 2016-11-10 | Reiterato | Needham | Buy |
| 2016-08-10 | Reiterato | Maxim Group | Buy |
| 2016-06-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-02 | Reiterato | Needham | Buy |
| 2016-02-29 | Reiterato | Wedbush | Outperform |
| 2015-11-11 | Reiterato | Needham | Buy |
| 2015-08-18 | Reiterato | WBB Securities | Strong Buy |
| 2015-08-10 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Omeros Corporation Borsa (OMER) Ultime notizie
Quantitative breakdown of Omeros Corporation recent moveVolume Spike & Weekly High Momentum Picks - newser.com
Omeros Corporation stock outlook for YEARJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Wealth Enhancement Advisory Services LLC Has $84,000 Stock Holdings in Omeros Corporation $OMER - Defense World
Can Omeros Corporation stock sustain institutional interestBull Run & Capital Efficient Trading Techniques - newser.com
Omeros (NASDAQ:OMER) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
What institutional flow reveals about Omeros CorporationTrade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Lobbying Update: $30,000 of OMEROS CORPORATION lobbying was just disclosed - Quiver Quantitative
Omeros surges 22% on clarity for BLA resubmission for narsoplimab - MSN
How to build a dashboard for Omeros Corporation stockWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Retail investors who hold 53% of Omeros Corporation (NASDAQ:OMER) gained 10%, institutions profited as well - simplywall.st
Mydriasis Market: Epidemiology, Therapies, and Key Players include Théa Laboratories, Omeros Corporation, Ocuphire Pharma. - Barchart.com
Intraday pattern recognizer results for Omeros CorporationJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com
Omeros Corporation stock trend forecast2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
What moving averages say about Omeros CorporationMarket Performance Recap & Real-Time Stock Price Movement Reports - newser.com
Is Omeros Corporation a good long term investmentInsider Buying Signals & Build Wealth With Strategy - earlytimes.in
Using RSI to spot recovery in Omeros CorporationAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN
Omeros Corporation Completes Promising Phase 2 Study on OMS906 for PNH - TipRanks
What analysts say about Omeros Corporation stockTechnical Breakout Signals & Receive Monthly Expert Trading Blueprints - earlytimes.in
Omeros Corporation (NASDAQ:OMER) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Will Omeros Corporation price bounce be sustainablePortfolio Profit Report & Long-Term Growth Plans - newser.com
Omeros (NASDAQ:OMER) Upgraded at Wall Street Zen - MarketBeat
Goldman Sachs Group Inc. Sells 30,445 Shares of Omeros Corporation $OMER - Defense World
Fund Flows: Will Omeros Corporation benefit from rising consumer demandWeekly Gains Report & Risk Managed Investment Strategies - خودرو بانک
Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN
Omeros (NASDAQ:OMER) Stock Rating Upgraded by Wall Street Zen - Defense World
Omeros Corporation stock trendline breakdownRecession Risk & Accurate Buy Signal Notifications - newser.com
Omeros Corporation Azioni (OMER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):